Antidiabetic Agents and Bone Quality: A Focus on Glycation End Products and Incretin Pathway Modulations
{{output}}
Diabetes mellitus is associated with inadequate bone health and quality and heightened susceptibility to fractures, even in patients with normal or elevated bone mineral density. Elevated advanced glycation end-products (AGEs) and a suppressed incretin pathway... ...